In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents-Reference-Cited by-同舟云学术

In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents

Published:2007-07 Issue:7 Volume:51 Page:2587-2590
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Almyroudis Nikolaos G.¹,Sutton Deanna A.²,Fothergill Annette W.²,Rinaldi Michael G.²³,Kusne Shimon⁴

Affiliation:

1. Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York

2. Fungus Testing Laboratory, Department of Pathology

3. Audie L. Murphy, South Texas Veterans Health Care System, San Antonio, Texas

4. Mayo Clinic Arizona, Phoenix, Arizona

Abstract

ABSTRACT We evaluated the in vitro susceptibilities of 217 zygomycetes to amphotericin B, ketoconazole, fluconazole, itraconazole, voriconazole, posaconazole, caspofungin, and flucytosine. The significant in vitro activity of posaconazole against several species appears to support its reported clinical efficacy. Decreased susceptibility to amphotericin B was noted with Cunninghamella bertholletiae .

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00452-07

Reference30 articles.

1. Almyroudis, N. G., D. A. Sutton, P. Linden, M. G. Rinaldi, J. Fung, and S. Kusne. 2006. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am. J. Transplant.6:2365-2374.

2. In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus and Fusarium Isolates

3. Pharmacokinetics, Excretion, and Mass Balance of Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate in Humans

4. Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi

5. Dannaoui, E., J. Meletiadis, J. W. Mouton, J. F. G. M. Meis, P. E. Verweij, and the Eurofong Network. 2003. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J. Antimicrob. Chemother.51:45-52.

Cited by 249 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternative ergosterol biosynthetic pathways confer antifungal drug resistance in the human pathogens within the Mucor species complex;mBio;2024-08-14

2. An interesting report of COVID-19 associated mucormycosis (CAM) cases by two different species of Mucorales;Indian Journal of Medical Microbiology;2024-07

3. Fatal hepatic mucormycosis in an allogeneic hematopoietic-stem cell transplanted patient: Case report of a rare presentation and review of the literature;Journal of Infection and Chemotherapy;2024-06

4. Exposure to resistant fungi across working environments and time;Science of The Total Environment;2024-05

5. Molecular mechanisms that govern infection and antifungal resistance in Mucorales;Microbiology and Molecular Biology Reviews;2024-03-27